GMO is a Boston asset manager co-founded in 1977 by Jeremy Grantham with Richard Mayo and Eyk Van Otterloo, known for valuation-driven dynamic asset allocation built on long-horizon mean reversion. Grantham is famous for calling historic bubbles, warning publicly ahead of both the 2000 dot-com crash and the 2008 financial crisis. Flagship publications include the GMO Quarterly Letter (now written by Asset Allocation co-heads Ben Inker and John Pease), Grantham's Viewpoints essays and the 7-Year Asset Class Forecast.

This report argues that rising inflation is a bigger threat to your portfolio than a recession. With stocks and bonds already expensive, higher inflation would force interest rates up, causing both to fall sharply. For example, a classic 60/40 stock-bond portfolio could lose over 40% in an inflation scenario, versus about 20% in a crisis. The author warns against relying on bonds for safety and suggests considering inflation-protected assets (like TIPS) and shorter-term investments. It's worth reading because it uses data to show that the biggest risk might not be what you expect.
GMO's Q3 2017 letter discusses the outlook for U.S. inflation and its potential impact on investment portfolios. The core argument is that although the U.S. economy is near full employment and inflation is close to the Federal Reserve's target, the actual trajectory of inflation remains puzzling, an
This chapter focuses on the puzzle of the US inflation outlook and its potential impact on investment portfolios. Author Ben Inker notes that despite the US economy being near full employment and inflation once reaching the Fed's target, the actual inflation trajectory in 2017 was puzzling—core CPI fell from 2.2% to 1.7%, contradicting moderate GDP growth. This uncertainty makes whether interest rates can return to "normal levels" a key question.
The author's central judgment is: A significant rebound in inflation represents the greatest risk to current portfolios, with destructive potential that could exceed that of an economic recession. The counterintuitive aspects are:
1. The Disconnect Between Inflation and Interest Rates:
2. The Failure of Historical Models:
| Asset Class | Cumulative Total Return (2011-2017) |
|---|---|
| SPDR S&P 500 ETF | ~120% |
| PowerShares Low Volatility ETF | ~100% |
US Core CPI rose from ~1% in 2011 to a peak of 2.3% in 2012, hovering around 2.2% in 2016, close to the Fed's 2% target level
3. Quantifying the Impact of an Inflation Shock:
US Real GDP Growth bottomed at ~-4% during the 2009 financial crisis, then gradually recovered, approaching the potential growth rate of 1.8%-2% in 2016
The author further distinguishes two market mindsets: TINA (There Is No Alternative) and TIAOA (There Is An Okay Alternative). The core of this shift is that a small rise in the expected return of low-risk assets (like bonds) could have a disproportionate impact on the current high-valuation market.
| Market Mindset | Core Characteristic | Investor Behavior | Impact on Stock Valuations | Historical Example (2010-2023) |
|---|---|---|---|---|
| TINA | Extremely low yields on low-risk assets | Forced to buy stocks | Pushes valuations to historical highs | 2010-2020, S&P 500 Shiller P/E rose from 20 to 38 |
| TIAOA | Low-risk asset yields rebound to "okay" level | Funds flow back to bonds | Valuations under pressure, potential 20-30% correction | 2022, S&P 500 fell 19%, bond yields rose |
| TIAPDGA | Low-risk asset yields are "pretty darn good" | Significant reduction in stocks | Sharp valuation contraction, potential halving | 2000-2002 dot-com bubble burst, S&P 500 fell 49% |
The author constructs two extreme scenarios—an Economic Crisis (similar to the Great Depression) and an Inflation Problem (moderate inflation)—and compares their impact on a 60/40 portfolio. The key finding is that the destructive power of the inflation scenario far exceeds that of the economic crisis.
Core CPI fluctuated between 1.5%-2.3% from 2011-2016; the 2017 data (green line) shows a decline to ~1.7%, below the Fed's target
The author emphasizes that the current Shiller P/E and Hussman P/E for the S&P 500 are both about 93% higher than their long-term medians, implying a 48% decline to revert to the median. However, the market has been below the median only 2-4% of the time over the past 25 years, suggesting this median has lost practical relevance.
The performance of a traditional portfolio (60% stocks / 40% bonds) in an inflation scenario is far worse than in an economic crisis scenario, contradicting the common investor belief that "bonds hedge deflation." The author's quantitative analysis reveals:
US Real GDP Growth recovered from -4% in 2009; the 2017 data (green line) shows a rebound to ~2%, near potential GDP growth
The sequel further strengthens the argument that "other assets are difficult to effectively hedge inflation" and adds key mechanisms:
The sequel introduces comparative data on the US Phillips Curve to argue why current inflation risk is being overlooked by the market:
| Period | Relationship between Unemployment & Wage Growth (Slope) | Key Characteristic |
|---|---|---|
| 2000-2008 | Significantly negative (traditional expectation) | When unemployment fell below 4%, wage growth rose above 4% |
| 2008-2017 | Slope declined by ~80% | Unemployment fell from 10% to 4%, wage growth only rose from 2% to 2.5% |
The cumulative total returns of the Low Volatility ETF and the S&P 500 ETF moved in close tandem from 2011-2017, both rising from 0% to ~120%
The sequel proposes a theoretically perfect hedging tool—Inflation Swaps—but points out its fatal flaw:
The sequel presents a somewhat controversial view: Emerging Market (EM) stocks may be more resilient to inflation, for the following reasons:
The Shiller P/E and Hussman P/E of the S&P 500 fluctuated from 1881-2016, reaching approximately 28x and 22x respectively in 2016, a premium of ~93% over the long-term median
The sequel summarizes GMO's actual measures in its benchmark-free portfolios:
| Asset Class | Inflation Protection Ability | Primary Risk | Notes |
|---|---|---|---|
| Traditional Bonds | Very Poor | Price collapse due to rising real rates | Longer duration = larger loss |
| TIPS | Moderate | Still lose money, but less than traditional bonds | Prices fall when real yields rise |
| Real Estate/Infrastructure | Low to Moderate | Leverage amplifies real rate shock | Nominal cash flows may rise, but valuations fall |
| Natural Resources/Resource Stocks | Conditionally High | Only effective if resource price gains exceed overall inflation | Futures indices have long underperformed spot |
| Inflation Swaps | Very High | Severe losses in deflation scenario | Perfect hedge but costly |
| Emerging Market Stocks | Uncertain | High volatility, but potentially more resilient | Valuation advantage is the current primary reason |
The percentage deviation of S&P 500 dividends from trend fluctuated from 1900-1995, falling to -20% during the Great Depression of the 1920s and rising to +18% in the post-WWII 1940s
GMO's three internal assumptions about the market's return path, while converging on long-term (20-year) returns (US stock real return 2.5%-3%), show significant differences in short- and medium-term (7-year) expectations, directly impacting asset allocation strategies. The following table compares key data:
| Path | Proponent | Speed of Reversion | 7-Year Expected Return (US) | 20-Year Expected Return (US) | Core Assumption |
|---|---|---|---|---|---|
| Fast Reversion | James Montier | Sharp short-term decline to pre-1998 levels | Very low (potentially negative) | 2.5%-3% | One-time market correction to historical valuation mean |
| 7-Year Reversion | Ben Inker | Gradual reversion to a new normal over 7 years | Slightly higher than James | 2.5%-3% | Valuation center shifts up, but long-term return unchanged |
| Slow Reversion | Jeremy Grantham | 20-year reversion to 2/3 of the mean | ~2.5% | 2.5%-3% | Structural factors (monopoly, aging, etc.) delay reversion |
Key Insight: Although the 20-year return ranges overlap significantly, the 7-year path differences determine the relative value of cash, bonds, and stocks. Under Grantham's slow reversion assumption, stocks offer a higher premium over cash (S&P 500 real return 2.5% vs. cash near 0%), weakening the "option value" of cash and the safe-haven attributes of long-term bonds.
The Fed's median estimate for the longer-term federal funds rate fell steadily from 4.3% in 2012 to ~2.9% in 2017, sitting between a "purgatory equilibrium" (3.3%) and a "hell equilibrium" (1.5%)
The five structural factors Grantham lists (political influence, central bank management, population aging, income inequality, slowing innovation) are not easily reversible in the short term. Using historical data as a reference:
These factors combined make it difficult for market valuations (e.g., S&P 500 P/E) to quickly fall back to the pre-1998 range of 15-18x; instead, they might stabilize around 20-22x, leading to persistently low long-term returns.
Grantham cites Chapter 12 of Keynes's General Theory, pointing out that career risk is the central contradiction in asset allocation:
Grantham points out that after the 1990s, the influx of quantitative models and highly educated analysts significantly eroded the excess returns of "low P/E / low P/B" strategies:
In the inflation scenario, stocks fall 53%, bonds fall 25%, and the 60/40 portfolio falls 42%; in the depression scenario, stocks fall 40-48%, bonds rise 14%, and the 60/40 portfolio falls 18-23%
Grantham's conclusion is that in a "globally overvalued" environment, only Emerging Market (EM) stocks are attractive:
Actionable Advice: Overweight EM stocks, hold a moderate position in EAFE, and completely avoid US stocks. However, be wary of career risk—if EM falls 20% in the short term, clients may question the strategy while the US market continues to rise (as actually happened from 2017-2021).
The severe market crashes of 2000 and 2007 clearly reveal a key fact: efficiency has not improved one iota at the asset class level. The market peak in 2000 offered one of the most significant combinations of asset class mispricing in history. Value stocks and small-cap stocks were never cheaper relative to growth stocks and large-cap stocks. Small caps appeared to need a 70-percentage-point rally just to catch up with large caps—and they did exactly that. Even more striking, US REITs yielded 9.1% at the market peak, while the S&P 500 yielded a historically low 1.5%—all rationalized by a mere 1% annual difference in dividend growth! When the S&P 500 fell 50%, the REIT index rose nearly 30% (small-cap value stocks also rose 1-2%, performing well). Newly issued long-term real bonds (TIPS) yielded 4.3%, while conventional long-term bonds yielded 5% (a real yield of 3.5%). All of this was astonishing. Then, in 2007-08, the world saw the most widespread overpricing of assets ever, exceeding one standard deviation. Thus, over the past 20 years, major opportunities at the asset class level have persisted and have even been more favorable compared to the "good old days."
Unlike the micro level, where increased acceptability and reduced career risk have narrowed value opportunities, there is nowhere to hide at the asset class level. Moving to cash too early can quickly unravel your business or career; exiting too late makes you appear useless. In short, investing at the asset class level remains dangerous for careers and profits, hence inefficient, occasionally offering excellent opportunities with the old warnings attached.
The Phillips Curve from 2000-2008 had a negative slope, with unemployment and wage growth negatively correlated; from 2008-2017, the curve flattened, with the relationship weakening by ~80%
This leads to today's theme and Chart 1, which shows GMO's 7-year forecasts, including those for Emerging Market value stocks. Chart 2 illustrates how significant the estimated return advantage of EM value stocks is over the next-best asset in our dataset, compared to the largest gaps available in recent years. However, Chart 3 (from Minack and Associates in Sydney) suggests that GMO's forecasts may still underestimate the opportunity in EM stocks. It plots a simple Shiller P/E (price divided by 10-year inflation-adjusted average real earnings). I deliberately use an external source for cross-validation and to imply that GMO's estimates are conservatively safe (discussed later). Note that at the recent low in February 2016 (point 1), EM stock P/Es were even lower than after the 2009 crash! This is remarkable. Meanwhile (point 2), US stock P/Es rose from 12x to 22x, creating a spread of nearly 100 percentage points in favor of the US over EM in just 7 years. The EM index traded at 38x P/E at the end of 2007 (point 3), a 52% premium over the US index's 25x (by any measure). It was again at a premium after the 2011 crash. And early last year, the US enjoyed a 120% premium in reverse. When you look at the absolute and relative volatility of these three indices in Chart 3, doesn't it suggest that even with imperfect predictive ability, there are opportunities to make money and avoid pain? This undoubtedly indicates old-fashioned extreme market inefficiency at the asset class level.
| Metric | End of 2007 (Point 3) | Feb 2016 (Point 1) | Aug 2017 (Point 2) |
|---|---|---|---|
| US Stock Shiller P/E | 25x | 22x | 22x |
| EM Stock Shiller P/E | 38x | Below 2009 level | Below 20-year average |
| US vs. EM Premium | EM premium 52% | US premium 120% | US premium ~100% |
From the absolute valuation perspective of Chart 3, two more points are worth noting: 1) The P/E of Developed Markets ex-US (DM ex-US) is far below its 20-year average and 40% lower than the US; 2) The EM P/E is 65% lower than its 2007 peak. The fact that it reached such a high level in 2007 was certainly a problem, but its existence well illustrates the chaotic nature of asset class pricing.
Assuming you are convinced by the above, let me set a trap. Last spring (or year-end), how many of your institutions had a 10% allocation to EM stocks? My informal survey at four regional conferences showed only 10-20%. So, how many had over 20%? Very few, perhaps 5% or less. Given the opportunity then and the scarcity of opportunities elsewhere, how much should we at GMO and you have allocated to EM stocks? How much should we allocate today? Today, in our benchmark-free allocation strategy, we have 25% in EM stocks plus 3% in EM debt (very similar, about two-thirds), so roughly 27%.
Let me tell a story. In mid-December last year, I told my colleagues in the asset allocation department that I was going to put up to 50% of my sister's and children's pension funds into EM. (I didn't mention it in the quarterly letter because it was preempted by the suddenly hotter topic of "The Road to Trumpville." I regret that, as the shift to EM proved timely, but everything has a cost. However, I did describe this approach as a "kamikaze portfolio" at our annual client meeting the previous November.) Obviously, "up to 50%" is much higher than 27%. (My sister and children are currently allocated about 55%. Why not 100% then? That's a good and difficult question. I suspect a lack of courage.) But the problem is this: many reasonable and experienced people, both inside GMO and among clients, are increasingly worried about an imminent major market decline, even a crash. Now imagine that this year is the start of an 18-month decline of 40% for the S&P 500 and 50% for EM (due to its higher beta), as many expect in such a scenario. What would happen to a manager with a 40% EM allocation? Nothing good. A 40% bet would not even be considered prudent (especially in hindsight), where prudence is defined as the normal behavior of the vast majority of investment professionals. In contrast, my investment-ignorant sister would wait happily in her ignorance—a perfect demonstration of the enormous difference that being completely free of career risk makes.
GMO forecasts a real return of -4.4% to -6.5% for US large-cap stocks over the next 7 years, -6.5% for US small-cap low-quality stocks, and +6.7% for EM value stocks, an advantage of 11-13 percentage points
Grantham reveals the fatal flaw of traditional investment strategies through the Stalin experiment. Based on GMO's 7-year forecast (Exhibit 1), the cumulative real return of a standard 65/35 portfolio is only 8.2% (annualized <1%). Even with a conservative 2% upward adjustment (annualized 3%), it remains far below the 4.5% survival threshold. He estimates the survival probability is less than 15%, likening it to "Russian roulette with all chambers loaded" (original footnote 2).
In contrast, a 100% allocation to EM stocks (with two-thirds tilted towards value) yields a blended annualized real return of 5.7%, approaching 6% after the conservative adjustment. Based on Minack's 14.5x Shiller P/E, the earnings yield for EM is 6.9% (100/14.5), still around 6% after deducting 1% for normal frictional costs. Grantham estimates the survival probability for this strategy is at least 70%. This comparison reveals the survival advantage of extreme concentration in the long run.
| Strategy | Annualized Real Return (GMO Forecast) | Adjusted Annualized Return (+2% Conservative) | Survival Probability |
|---|---|---|---|
| Standard 65/35 Portfolio | <1% | ~3% | <15% |
| 100% EM (Value-Tilted) | 5.7% | ~6% | ≥70% |
Grantham simulates a "jump out to cash and wait" strategy, assuming the investor has extraordinary skill: missing the last 18 months of a rally (e.g., late 1997), perfectly capturing a 2-year decline cycle (e.g., 1 year in 2008, 3 years in 2000), and re-entering after missing only 6 months of the subsequent rebound. Even so, with the final 6 years of a 10-year test period invested in a normal diversified manner (assuming returns equal to the pre-1998 average), the 10-year average real return barely exceeds 3%. While this is better than the standard portfolio's <1%, it still falls short of the 4.5% Stalin threshold.
Key data: From late 1997 to 2000, the market rally lasted 2.5 years (Grantham's team missed it); the 2008 decline lasted 1 year, the 2000 decline lasted 3 years. Even with perfect execution, the return ceiling for the cash strategy is only 3%, far below the 5.5%+ of the EM concentrated strategy.
Grantham points out that EM's performance in bear markets is not necessarily worse; relative valuation is the key variable. He uses the example of small-cap stocks in 2000: when small caps were in the cheapest third relative to large caps (as in 1973 and 2000), their decline was less than the market (Beta < 1). In the 2000 crash, small caps fell only 40% as much as large caps, small-cap value stocks even rose 2-3%, while the S&P 500 plunged 50%.
EM's historical performance validates this:
The predicted return advantage of the best asset over the next-best asset rose from ~0.5% in 2012 to ~5.5% in 2016, a historical high since 1994
Since the February 2016 low (Shiller P/E 11x), the MSCI Emerging Index has outperformed the US market by 11% in total USD return, primarily driven by currency, with relative P/E changing by less than 5%. Grantham emphasizes that this gain is trivial in the context of historical cycles:
The current EM Shiller P/E of ~14.5x implies a real return of 5.9% (after deducting frictional costs); GMO's adjusted figure is ~16x, with an earnings yield of 6.25% and a net return of 5.25%. Grantham specifically notes that excluding banks and resource stocks reduces EM's relative attractiveness, but he believes the resource cycle has turned (oil prices may rise for 3 years), which actually benefits EM.
Grantham concludes that in reality, pension fund managers are constrained by "two-year career risk" (short-term performance evaluation), forcing them to maintain a superficially "prudent" diversification that leads to future 10-year returns of only 1-3%. In contrast, the extreme setting of the Stalin experiment (life-threatening) forces investors to abandon short-term compliance and adopt a long-term survival strategy. This contradiction reveals a systemic flaw in institutional investing: a fundamental conflict between short-term incentive structures and long-term return objectives.
Grantham introduces Exhibit 4, which shows the relative wealth changes between the S&P and EAFE ex-Japan from 1976-2016, revealing significant cyclical fluctuations. Key data points are as follows:
US CAPE fell from 45x in 2000 to ~25x in 2017, still about 65% higher than EM (~15x) and a ~93% premium over the historical average
| Cycle Phase | Relative Return (S&P vs. EAFE ex-Japan) | Currency Contribution | Duration (approx.) |
|---|---|---|---|
| 1976-1980 | S&P +84% | Currency +28% | 4 years |
| 1980-1988 | EAFE ex-Japan +74% | Currency +95% | 8 years |
| 1988-1994 | S&P +96% | Currency +90% | 6 years |
| 1994-2000 | EAFE ex-Japan +75% | Currency +42% | 6 years |
| 2000-2008 | S&P +105% | Currency +58% | 8 years |
| 2008-2016 | EAFE ex-Japan +9% | Currency +34% | 8 years |
Core View:
Comparative Data:
| Scenario | Forecast Return | Basis |
|---|---|---|
| Stock valuation reversion only | +28% | GMO 7-year model |
| Stock + moderate currency appreciation | +38% | 1.28 × 1.08 |
| Cycle extreme (overshoot fair value) | +76% | Historical cycle average (+74% to +75%) |
From 1976-2016, the relative wealth accumulation of EAFE ex-Japan vs. the S&P showed multiple cycles; in 2016, the US relative performance was at a high of ~1.9x, near historical peaks
In Postscript 1, Grantham suggests that for a "Stalin-style" extreme survival scenario (e.g., a pension fund), the original 100% EM allocation could be adjusted to 80% EM / 20% EAFE. Reasons:
In Postscript 2, Grantham adds arguments for early-stage VC:
This section, through 45 years of cyclical data for EAFE ex-Japan, a quantitative model for currency effects, and supplementary arguments for early-stage VC, strengthens the core view that "non-US assets (especially EM and EAFE) are significantly undervalued." Grantham's allocation advice expands from pure EM to an EM/EAFE combination and introduces early-stage VC as a higher-risk-return option, reflecting a balance between "courage" and "rationality" in extreme scenarios.